Concepedia

Author

Stanley E. Grogg

Marshall University

Also Known As

S E Grogg, S. Grogg, Stanley E Grogg, Stanley E. Grogg, Stanley Grogg

23

Publications

317

Citations

7

H-Index

10

Concepts

All Affiliations

Marshall UniversityChildren's Mercy HospitalMedical Research AssociatesGlaxoSmithKline (United States)Oklahoma State University Center for Health Sciences
SE

About

Stanley E. Grogg is an author at Marshall University specializing in developmental biology, histopathology, and neurogenetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

27

2

Pathology

1

1

27

3

Developmental Biology

1

1

27

4

Ear Molding

1

1

27

5

Immunodeficiencies

1

1

27

Stanley E. Grogg

×

6

Publications

292

Citations

6

H-Index

YearCitations

Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America

Larry K. Pickering, Carol J. Baker, Gary L. Freed,

Clinical Infectious Diseases

2009

188

Microcephaly, short stature, and developmental delay associated with a chemotactic defect and transient hypogammaglobulinaemia in two brothers.

Burhan Say, Nancy Barber, Gerald C. Miller,

Journal of Medical Genetics

1986

27

Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children Twelve to Fourteen Months of Age

Mark M. Blatter, Nicola P. Klein, Julie S. Shepard,

The Pediatric Infectious Disease Journal

2012

24

Mucoepidermoid bronchial adenoma in a 6-year-old girl: A case report and review of the literature

Robert Archer, Stanley E. Grogg, Steve P. Sanders

Journal of Thoracic and Cardiovascular Surgery

1987

22

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months

Maurice A. Mufson, Carlos Javier Gómez Díaz, M. Leonardi,

Journal of the Pediatric Infectious Diseases Society

2014

20

Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin

Andrea A. Berry, Remon Abu‐Elyazeed, Clemente Díaz-Pérez,

Human Vaccines & Immunotherapeutics

2017

11

Page 1